Tachykinin antagonist dipeptides
AssigneeFujisawa Pharmaceutical Co., Ltd.
InventorsMasaaki Matsuo, Daijiro Hagiwara, Hiroshi Miyake
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compounds of the following formula: ##STR1## wherein R.sup.1 is a group of the formula ##STR2## "X" is CH.sub.2 or N, "Z" is O, S, or N--R.sup.6, "A" is an amino acid residue, and Y, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, and R.sup.7 are substituent variables as defined herein. The compounds are antagonists of tachykinin, and as such are useful for alleviation of pain and for treatment of disorders including asthma, bronchitis, rhinitis, conjunctivitis, dermatitis, arthritis, and urticaria.
Claims14
A compound of the formula:
- ##STR142## wherein R.sup.1 is a group of the formula ##STR143## wherein the symbol of a line and a dotted line represent a single bond and X is CH.sub.2 or NH, or said line and dotted line represent a double bond and X is CH or N,
- Z is O, S or N--R.sup.6,
- wherein R.sup.6 is hydrogen, lower alkyl, or N,N-di(lower)alkylamino(lower)alkyl;
- R.sup.2 is hydrogen or lower alkyl;
- R.sup.3 is lower alkyl, carboxy(lower)alkyl, esterified carboxy(lower)alkyl, carbamoyl(lower)alkyl, lower alkylamino(lower)alkyl, hydroxy(lower)alkyl, acyloxy(lower)alkyl, halo(lower)alkyl, carboxy(lower)alkoxy, esterified carboxy(lower)alkoxy, halogen, lower alkoxy, nitro, amino, or an acylated amino group;
- R.sup.4 is lower alkyl, carboxy(lower)alkyl or esterified carboxy(lower)alkyl, and
- R.sup.5 is ar(lower)alkyl selected from the group consisting of mono-, di- and triphenyl(lower)alkyl or pyridyl(lower)alkyl, or ##STR144## represents a heterocyclic moiety selected from the group consisting of 1-indolinyl, 2-isoindolinyl, 1, 2, 3, 4-tetrahydroquinolin-1-yl and 1, 2, 3, 4-tetrahydroisoquinolin-2-yl;
- R.sup.7 is hydrogen, lower alkyl, carboxy(lower)alkyl, esterified carboxy(lower)alkyl, carbamoyl(lower)alkyl, lower alkylamino(lower)alkyl, hydroxy(lower)alkyl, acyloxy(lower)alkyl, halo(lower)alkyl carboxy(lower)alkoxy, esterified carboxy(lower)alkoxy, halogen, lower alkoxy, nitro, amino, or an acylated amino group;
- A represents an amino acid residue, wherein said amino acid is selected from the group consisting of D- or L-proline, D- or L-didehydroproline, D- or L-hydroxyproline, and D- or L-mercaptoproline,
- wherein if said amino acid is hydroxyproline or mercaptoproline, the amino acid side chain is optionally substituted with a moiety selected from the group consisting of lower alkanoyl, lower alkoxycarbonyl, trihalo(lower)alkoxy-carbonyl, C.sub.6 -C.sub.10 ar(lower)alkoxycarbonyl, lower alkylsulfonyl, lower alkoxyalyl, C.sub.6 -C.sub.10 arylsulfonyl, halo C.sub.6 -C.sub.10 ar(lower)-alkoxycarbonyl, carboxy(lower)alkanoyl, glycyl, .beta.-alanyl, N-lower alkoxycarbonylglycyl, N-lower alkoxycarbonyl-.beta.-alanyl, N,N-di(lower)alkylamino-(lower)alkanoyl, carboxyalyl, morpholino-carbonyl, amino(lower)alkanoyl, N-C.sub.6 -C.sub.10 ar(lower)alkoxycarbonyl-amino(lower)alkanoyl, threonyl, N-lower alkoxycarbonyl-threonyl, N-lower alkanoylthreonyl, N-lower alkoxycarbonyl(lower)alkyl-N-lower alkoxycarbonylamino-(lower)alkanoyl, .alpha.-glutamyl, N-C.sub.6 -C.sub.10 ar(lower)alkoxycarbonyl-O-C.sub.6 -C.sub.10 ar(lower)alkyl-.gamma.-glutamyl, lower alkyl, carboxy(lower)alkyl, esterified carboxy(lower)alkyl, morpholino, glycino amide, threonino amide, N'-glutamylamino, N-lower alkylamide, di(lower)alkylamino, C.sub.6 -C.sub.10 ar(lower)alkyl, trihalo(lower)alkyl and lower alkoxycarbonyl(lower)alkyl;
- and
- Y is a valence bond, lower alkylene or lower alkenylene;
- or a pharmaceutically acceptable salt thereof.
A compound selected from the group consisting of:
- ##STR146##
A compound of the formula:
- ##STR147##
A compound of the formula:
- ##STR148##
Dependencies are inferred from the claim text.